Morgan Stanley Maintains Equal-Weight on Moderna, Lowers Price Target to $32

Benzinga · 04/09 13:50
Morgan Stanley analyst Matthew Harrison maintains Moderna (NASDAQ:MRNA) with a Equal-Weight and lowers the price target from $39 to $32.